NMPA Approval

Hydromorphone Hydrochloride Injection

Approval Number

国药准字H20217022

Registration Date

August 15, 2022

Previous Approval Numbers

国药准字H20217022

Drug Information

Generic Name

盐酸氢吗啡酮注射液

Trade Name

锐宁

Dosage Form

注射剂

Strength

1ml:1mg

Drug Type

化学药品

Registration Date

August 15, 2022

Company Address

湖北省宜昌开发区大连路19号

Company Address

湖北省宜昌开发区大连路19号

Empowering clinical research with data-driven insights and AI-powered tools.

盐酸氢吗啡酮注射液 - NMPA 批准文号 | MedPath